Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: New Brunswick NJ, New York NY, Pittsburgh PA, Boston MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for
Solid Tumors With HRAS Alterations,
Location: New Brunswick NJ, Pittsburgh PA, Boston MA, Columbus OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Brunswick NJ, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase2, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: New Brunswick NJ, Hershey PA, Harrisburg PA,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: New Brunswick NJ, Livingston NJ, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04172532

Phase1, Phase2, Recruiting

Impella RP Flex with Smart Assist

for
Right Ventricular (RV) Dysfunction
Location: New Brunswick NJ, New York NY, Bronx NY, Pittsburgh PA,
Sponsor: Abiomed Inc.

Sex: All

Age: 0+

Code: NCT06637644

Recruiting

Abbott Structural Heart Device Registry

for
Heart Diseases, ASD - Atrial Septal Defect,
Location: New Brunswick NJ, New York NY, Pittsburgh PA,
Sponsor: Abbott Medical Devices

Sex: All

Age: 0+

Code: NCT06590467

Recruiting

Longitudinal Performance of Epi proColon

for
Colorectal Cancer, Colorectal Neoplasms
Location: New Brunswick NJ, Danville PA, Morgantown WV, Durham NC,
Sponsor: Epigenomics, Inc

Sex: All

Age: 50 - 70+

Code: NCT03218423

Recruiting

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

for
Aortic Aneurysm, Abdominal
Location: New Brunswick NJ, Hershey PA, Stony Brook NY,
Sponsor: Rijnstate Hospital

Sex: All

Age: 18+

Code: NCT05484115

Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for
Non-small Cell Lung Cancer
Location: Morristown NJ, Lancaster PA, Stamford CT, Albany NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06345729

Phase3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Morristown NJ, Hershey PA, Hackensack NJ, New York NY,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Morristown NJ, Lancaster PA, Hershey PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

for
Spinal Muscular Atrophy (SMA)
Location: Morristown NJ, Hershey PA, Stony Brook NY, New Haven CT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04174157

Recruiting

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

for
Lumbar Spinal Stenosis
Location: Chadds Ford PA, Voorhees NJ, Oxon Hill MD, Loveland OH,
Sponsor: Pacific Research Institute

Sex: All

Age: 18+

Code: NCT05504499

Recruiting

PECS Block in Partial Mastectomy for Postoperative Pain Control

for
Breast Cancer, Postoperative Pain, Opioid Use, Local Anesthesia
Location: Philadelphia PA
Sponsor: Main Line Health

Sex: Female

Age: 18+

Code: NCT04086394

Recruiting

Home PT vs FORCE PT

for
Osteoarthritis
Location: Philadelphia PA
Sponsor: Rothman Institute Orthopaedics

Sex: All

Age: 18+

Code: NCT02911389

Recruiting

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for
Uncontrolled Gout
Location: Hamilton NJ, Columbia MD, Oxon Hill MD, Duncansville PA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07388498

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Camden NJ, Newark DE, Hershey PA, York PA, Westbury NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Camden NJ, Bethesda MD, Pittsburgh PA, Lebanon NH,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase3, Recruiting